Skip to content

Clinical application of emergency bedside ultrasound technology under THIRD process in rapid diagnosis of unexplained shock

Clinical application of emergency bedside ultrasound technology under THIRD process in rapid diagnosis of unexplained shock

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000031072
Enrollment
Unknown
Registered
2020-03-21
Start date
2020-03-16
Completion date
Unknown
Last updated
2020-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shock

Interventions

Gold Standard:Systolic blood pressure 1.0, confirmed after at least three measurements during the first assessment
Index test:Ultrasound&#32
diagnosis&#32
using&#32
the&#32
THIRD&#32

Sponsors

Northern Jiangsu People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
19 Years to 92 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-95 years; 2. With systolic blood pressure 1.0 confirmed after at least three measurements during the first assessment; 3. Patients with at least one of the following hypoperfusion symptoms: unresponsiveness, mental status change (including unexplained severe anxiety), syncope, respiratory distress, severe fatigue or discomfort, severe chest pain or abdominal pain.

Exclusion criteria

Exclusion criteria: 1. With a general "hypotensive" state reported by patients or recordedin thehistory; 2. Patients referred from another hospital with a knowndiagnosis; 3. Patients with a shock index >1.0 or a systolic blood pressure greater than 120 mmHg before admission to the eICU.

Design outcomes

Primary

MeasureTime frame
Tamponade;Tensionpneumothorax;Heart;Inferiorvenacava;Respiratory system;Deep venous thrombosis;Dissection;

Countries

China

Contacts

Public ContactPing Geng

Northern Jiangsu People's Hospital

gengping97@163.com+86 18051061912

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026